Victory Capital Management
ZYME icon

Victory Capital Management’s Zymeworks ZYME Stock Holding History

Victory Capital Management’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.06M Sell
42,404
-501
-1% -$11.9K ﹤0.01% 1817
2025
Q4 		$1.13M Buy
42,905
+8,395
+24% +$183K ﹤0.01% 1774
2025
Q3 		$589K Sell
34,510
-100
-0.3% -$1.43K ﹤0.01% 2007
2025
Q2 		$434K Sell
34,610
-9,660
-22% -$115K ﹤0.01% 2081
2025
Q1 		$527K Sell
44,270
-7,310
-14% -$99.7K ﹤0.01% 2015
2024
Q4 		$755K Sell
51,580
-2,810
-5% -$39.3K ﹤0.01% 1920
2024
Q3 		$683K Sell
54,390
-3,910
-7% -$42.6K ﹤0.01% 1925
2024
Q2 		$496K Buy
58,300
+11,100
+24% +$98.8K ﹤0.01% 1980
2024
Q1 		$497K Buy
+47,200
New +$524K ﹤0.01% 1984
2023
Q3 		– Sell
-123,310
Closed -$1.07M – 2566
2023
Q2 		$1.07M Sell
123,310
-28,640
-19% -$256K ﹤0.01% 1644
2023
Q1 		$1.37M Buy
+151,950
New +$1.33M ﹤0.01% 1532
2021
Q3 		– Sell
-36,810
Closed -$1.28M – 2860
2021
Q2 		$1.28M Sell
36,810
-2,350
-6% -$74.6K ﹤0.01% 1806
2021
Q1 		$1.24M Sell
39,160
-1,740
-4% -$70.7K ﹤0.01% 1818
2020
Q4 		$1.93M Sell
40,900
-6,870
-14% -$319K ﹤0.01% 1526
2020
Q3 		$2.23M Sell
47,770
-23,930
-33% -$822K ﹤0.01% 1411
2020
Q2 		$2.59M Sell
71,700
-429,084
-86% -$15.8M ﹤0.01% 1352
2020
Q1 		$17.8M Buy
500,784
+241,241
+93% +$9.87M 0.01% 923
2019
Q4 		$11.8M Buy
259,543
+63,553
+32% +$2.31M 0.01% 966
2019
Q3 		$4.86M Buy
+195,990
New +$4.91M 0.01% 1171

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Victory Capital Management's ZYME Position: Q1 2026 in Review

Victory Capital Management reduced its Zymeworks (ZYME) stake by 1.2% in Q1 2026, selling an estimated $11.9K and leaving 42,404 shares worth $1.06M. The position accounts for ﹤0.01% of the portfolio, ranked #1817.

Victory Capital Management first reported a position in ZYME in Q3 2019 and has held it in 19 quarters since. The position peaked at $17.8M in Q1 2020. 211 funds tracked by Wall St. Rank hold ZYME as of Q1 2026.

  • Victory Capital Management held 42,404 shares of Zymeworks worth $1.06M as of Q1 2026.
  • Victory Capital Management sold 501 Zymeworks shares in Q1 2026, an estimated $11.9K.
  • Zymeworks made up ﹤0.01% of Victory Capital Management's portfolio in Q1 2026, its #1817 holding.
  • Victory Capital Management first reported a position in Zymeworks in Q3 2019 and has held it in 19 quarters since.
  • Victory Capital Management's Zymeworks position peaked at $17.8M in Q1 2020.
  • 211 funds tracked by Wall St. Rank held Zymeworks as of Q1 2026.

Based on Victory Capital Management's 13F filing for Q1 2026, filed 15 May 2026.